Clinical Trial

Automatically Transmitted Home Blood Pressure and Automated Patient Feedback in Hypertension Care: the AUTO 2 Trial

Study acronym: AUTO 2
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the effectiveness of automatically-generated medical advice to patients about to their home blood pressure monitoring results sent through patient portal messages compared to no automated advice and the effectiveness of automated transmission of remotely-obtained blood pressure values compared to self-reported values on systolic blood pressure at 1-year follow up in patients with uncontrolled hypertension whose physicians or advance practice providers provide primary care at Northwestern Medicine. Persistence of effects through 18 months will also be assessed.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Enrolling by Invitation 2026-05-13
Trial Details
NCT Number NCT07397260
Lead Sponsor Northwestern University
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Hypertension (HTN)
Enrollment 1,304 participants
Start Date 2026-05-04
Primary Completion 2028-04 (estimated)
Study Completion 2028-11 (estimated)
Updated on ClinicalTrials.gov 2026-05-12